Medindia LOGIN REGISTER
Medindia

Side effect(s) of Ertugliflozin


Review the side-effects of Ertugliflozin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

  Common:
Frequent urination, low blood sugar level, genital fungal infections

  Gastrointestinal:
Nausea, pain in the stomach, vomiting

  Cardiovascular:
Low blood volume, low blood pressure, faster heartbeat, increased LDL-cholesterol level in blood

  Nervous system:
Confusion, dizziness, headache, irritability, weakness

  Respiratory:
Difficulty in breathing, nasopharyngitis

  Kidney:
Urinary tract infections (pyelonephritis, urosepsis or bladder infections), pain or burning sensation while passing urine, blood in urine, reduced kidney function

  Others:
Foot ulcers or sores, fever, pain or tenderness in the lower limbs, pain in the back, reduced weight, increased thirst

• Some of the side effects mentioned above could be due to ketoacidosis.

Other Precautions :

• Ertugliflozin may increase urinary glucose excretion. This could result in positive test results for urinary glucose even in patients with adequate blood glucose control.
• Patients should be advised to not to stand up suddenly from sitting or lying position to prevent from falling due to the risk of orthostatic hypotension.
• Avoid alcohol consumption as it may cause fluctuations in blood sugar levels. • Do not change the dose of ertugliflozin or diet plan without the approval of the treating physician.
• Do not take extra tablets to make up the missed dose.

Drug Name : Ertugliflozin

Ertugliflozin generic • Ertugliflozin tablet is a sodium glucose co-transporter 2 (SGLT2) inhibitor which is prescribed for adult patients with type 2 diabetes as an adjunct therapy to diet control and exercise with a focus to improve glycemic control. • It is prescribed either as a monotherapy or in combination with metformin or sitagliptin .


Advertisement